# A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

> **NCT01917058** · PHASE2 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Abatacept
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01917058
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unfortunately we did not receive funding and therefore were not able to begin the trial.
- **Last updated:** 2014-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917058, "A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01917058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*